N188 is one of 2 small molecule programs targeting PET/CT Imaging. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in PET/CT Imaging
Gallium-68 Labelled (68ga-) FAP-2286
N188
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details